
    
      To characterize, in routine practice, non compliant patient to continuous positive airway
      pressure who can get a benefit of a bilevel positive airway pressure therapy as a second line
      treatment (Aircurve 10 VAutoTM ) To evaluate the clinical management of obstructive sleep
      apnea patients treated by Aircurve 10 VAutoTM , especially impact on compliance and residual
      apnea hypopnea Index.

      To evaluate Aircurve 10 VAutoTM benefit on quality of Life and quality of sleep
    
  